Gilead Sciences Inc
Company Profile
Business description
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Contact
333 Lakeside Drive
Foster CA 94404
USAT: +1 650 574-3000
E: investor_relations@gilead.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
18,000
Gilead Sciences Inc News & Analysis
stocks
The 10 best US dividend shares
stocks
The 10 best US dividend shares
stocks
The 10 best US dividend shares
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,995.70 | 23.70 | -0.30% |
| CAC 40 | 8,203.75 | 5.53 | -0.07% |
| DAX 40 | 18,694.58 | 47.64 | -0.25% |
| Dow JONES (US) | 39,431.51 | 81.33 | -0.21% |
| FTSE 100 | 8,419.29 | 4.30 | 0.05% |
| HKSE | 19,093.42 | 21.64 | -0.11% |
| NASDAQ | 16,388.24 | 47.37 | 0.29% |
| Nikkei 225 | 38,356.06 | 176.60 | 0.46% |
| NZX 50 Index | 11,618.09 | 34.07 | -0.29% |
| S&P 500 | 5,221.42 | 1.26 | -0.02% |
| S&P/ASX 200 | 7,726.80 | 23.20 | -0.30% |
| SSE Composite Index | 3,145.77 | 2.25 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.01 | 12.20% |
| Pantoro Ltd PNR | 0.08 | 0.01 | -6.98% |
| Telstra Group Ltd TLS | 3.65 | 0.02 | -0.55% |
| Pilbara Minerals Ltd PLS | 3.97 | 0.11 | -2.70% |
| Alumina Ltd AWC | 1.71 | 0.11 | 6.88% |
| Imugene Ltd IMU | 0.07 | 0.00 | 0.00% |
| South32 Ltd S32 | 3.62 | 0.01 | 0.28% |
| Carnarvon Energy Ltd CVN | 0.22 | 0.01 | 2.38% |
| Red 5 Ltd RED | 0.48 | 0.01 | 2.15% |
| Jupiter Mines Ltd JMS | 0.37 | 0.01 | -1.35% |